1. Employment of selective pharmacologically active natural compounds in treatment and management of osteoporosis
   Vishu Upmanyu et al, 2022, Bioactive Natural Products CrossRef
2. Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patients
   Wei Peng et al, 2022, PeerJ CrossRef
3. Alendronate modified mPEG-PLGA nano-micelle drug delivery system loaded with astragaloside has anti-osteoporotic effect in rats
   Yanhai Xi et al, 2022, Drug Delivery CrossRef
4. Association between miR-202, miR-211, and miR-1238 gene polymorphisms and risk of vitiligo
   Mahdieh Jafari Shahroudi et al, 2024, Archives of Dermatological Research CrossRef
5. Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis
   Krishan K. Thakur et al, 2021, Journal of Cellular Physiology CrossRef